For research use only. Not for therapeutic Use.
KALA（Cat No.:I044263）is a biotechnology company focused on delivering innovative therapies in ophthalmology. It utilizes its proprietary mucus-penetrating particle (MPP) technology to enhance drug delivery to the eye. KALA has developed treatments targeting eye conditions such as dry eye disease and ocular inflammation. Its flagship product, EYSUVIS®, is the first FDA-approved corticosteroid for short-term treatment of dry eye flares. The company’s pipeline includes biologics for front-of-eye diseases, reflecting a commitment to transforming patient care through advanced ocular therapeutics and strategic science-based innovation.
| CAS Number | 187987-64-0 |
| Molecular Formula | C144H248N40O35S |
| Purity | ≥95% |
| Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |
